Skip to main content

Bank of New York Mellon Corp

Bank

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1390777 NEW YORK, NY

Position in KNSA

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$14,870,353
+$14,033,123 QoQ
Shares Held
232,531
+1237.3% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 266 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. KNSA ranks #16 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KNSA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,870,353 232,531
2026-03-31 $837,230 17,388
2025-12-31 $596,927 14,471
2025-09-30 $1,263,100 32,529
2025-06-30 $878,217 31,739
2025-03-31 $2,706,487 121,859
2024-12-31 $2,414,167 122,051
2024-09-30 $2,290,807 91,669
2024-06-30 $2,149,719 115,143